Vincent Majanga, Ernest Mnkandla, Zenghui Wang, Donatien Koulla Moulla
{"title":"Active Contours Connected Component Analysis Segmentation Method of Cancerous Lesions in Unsupervised Breast Histology Images.","authors":"Vincent Majanga, Ernest Mnkandla, Zenghui Wang, Donatien Koulla Moulla","doi":"10.3390/bioengineering12060642","DOIUrl":null,"url":null,"abstract":"<p><p>Automatic segmentation of nuclei on breast cancer histology images is a basic and important step for diagnosis in a computer-aided diagnostic approach and helps pathologists discover cancer early. Nuclei segmentation remains a challenging problem due to cancer biology and the variability of tissue characteristics; thus, their detection in an image is a very tedious and time-consuming task. In this context, overlapping nuclei objects present difficulties in separating them by conventional segmentation methods; thus, active contours can be employed in image segmentation. A major limitation of the active contours method is its inability to resolve image boundaries/edges of intersecting objects and segment multiple overlapping objects as a single object. Therefore, we present a hybrid active contour (connected component + active contours) method to segment cancerous lesions in unsupervised human breast histology images. Initially, this approach prepares and pre-processes data through various augmentation methods to increase the dataset size. Then, a stain normalization technique is applied to these augmented images to isolate nuclei features from tissue structures. Secondly, morphology operation techniques, namely erosion, dilation, opening, and distance transform, are used to highlight foreground and background pixels while removing overlapping regions from the highlighted nuclei objects on the image. Consequently, the connected components method groups these highlighted pixel components with similar intensity values and assigns them to their relevant labeled component to form a binary mask. Once all binary-masked groups have been determined, a deep-learning recurrent neural network (RNN) model from the Keras architecture uses this information to automatically segment nuclei objects having cancerous lesions on the image via the active contours method. This approach, therefore, uses the capabilities of connected components analysis to solve the limitations of the active contour method. This segmentation method is evaluated on an unsupervised, augmented human breast cancer histology dataset of 15,179 images. This proposed method produced a significant evaluation result of 98.71% accuracy score.</p>","PeriodicalId":8874,"journal":{"name":"Bioengineering","volume":"12 6","pages":""},"PeriodicalIF":3.8000,"publicationDate":"2025-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12189801/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bioengineering","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.3390/bioengineering12060642","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0
Abstract
Automatic segmentation of nuclei on breast cancer histology images is a basic and important step for diagnosis in a computer-aided diagnostic approach and helps pathologists discover cancer early. Nuclei segmentation remains a challenging problem due to cancer biology and the variability of tissue characteristics; thus, their detection in an image is a very tedious and time-consuming task. In this context, overlapping nuclei objects present difficulties in separating them by conventional segmentation methods; thus, active contours can be employed in image segmentation. A major limitation of the active contours method is its inability to resolve image boundaries/edges of intersecting objects and segment multiple overlapping objects as a single object. Therefore, we present a hybrid active contour (connected component + active contours) method to segment cancerous lesions in unsupervised human breast histology images. Initially, this approach prepares and pre-processes data through various augmentation methods to increase the dataset size. Then, a stain normalization technique is applied to these augmented images to isolate nuclei features from tissue structures. Secondly, morphology operation techniques, namely erosion, dilation, opening, and distance transform, are used to highlight foreground and background pixels while removing overlapping regions from the highlighted nuclei objects on the image. Consequently, the connected components method groups these highlighted pixel components with similar intensity values and assigns them to their relevant labeled component to form a binary mask. Once all binary-masked groups have been determined, a deep-learning recurrent neural network (RNN) model from the Keras architecture uses this information to automatically segment nuclei objects having cancerous lesions on the image via the active contours method. This approach, therefore, uses the capabilities of connected components analysis to solve the limitations of the active contour method. This segmentation method is evaluated on an unsupervised, augmented human breast cancer histology dataset of 15,179 images. This proposed method produced a significant evaluation result of 98.71% accuracy score.
期刊介绍:
Aims
Bioengineering (ISSN 2306-5354) provides an advanced forum for the science and technology of bioengineering. It publishes original research papers, comprehensive reviews, communications and case reports. Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. All aspects of bioengineering are welcomed from theoretical concepts to education and applications. There is no restriction on the length of the papers. The full experimental details must be provided so that the results can be reproduced. There are, in addition, four key features of this Journal:
● We are introducing a new concept in scientific and technical publications “The Translational Case Report in Bioengineering”. It is a descriptive explanatory analysis of a transformative or translational event. Understanding that the goal of bioengineering scholarship is to advance towards a transformative or clinical solution to an identified transformative/clinical need, the translational case report is used to explore causation in order to find underlying principles that may guide other similar transformative/translational undertakings.
● Manuscripts regarding research proposals and research ideas will be particularly welcomed.
● Electronic files and software regarding the full details of the calculation and experimental procedure, if unable to be published in a normal way, can be deposited as supplementary material.
● We also accept manuscripts communicating to a broader audience with regard to research projects financed with public funds.
Scope
● Bionics and biological cybernetics: implantology; bio–abio interfaces
● Bioelectronics: wearable electronics; implantable electronics; “more than Moore” electronics; bioelectronics devices
● Bioprocess and biosystems engineering and applications: bioprocess design; biocatalysis; bioseparation and bioreactors; bioinformatics; bioenergy; etc.
● Biomolecular, cellular and tissue engineering and applications: tissue engineering; chromosome engineering; embryo engineering; cellular, molecular and synthetic biology; metabolic engineering; bio-nanotechnology; micro/nano technologies; genetic engineering; transgenic technology
● Biomedical engineering and applications: biomechatronics; biomedical electronics; biomechanics; biomaterials; biomimetics; biomedical diagnostics; biomedical therapy; biomedical devices; sensors and circuits; biomedical imaging and medical information systems; implants and regenerative medicine; neurotechnology; clinical engineering; rehabilitation engineering
● Biochemical engineering and applications: metabolic pathway engineering; modeling and simulation
● Translational bioengineering